<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK OnDemand

For Medtech Advisors, Consultants or Financial Services Providers

SmartTRAK is the most comprehensive and up-to-date market intelligence platform providing all the info you need in one place for crucial decision making. You can quickly get access to market, financial, product and competitive data along with interactive tools and dashboards that will help you maximize your project ROI.

We offer flexible contracting along with optional add-on industry analyst consultative support.

Strategic Analysis

  • Market Shares & Sizing
  • Partnerships & Alliances
  • Growth Rates
  • Competitive Landscape Assessments
  • Exit Strategy
  • Regulatory

Financial Analysis

  • Historic Revenues
  • Quarterly Financial Reviews
  • Market & Company Revenues & Market Caps
  • M&A Transaction History

Data Analysis

  • Procedure Volumes and Trends for US and Global
  • Brands and Pricing Analytics
  • Treatments by Site of Care (Wound Care)

Daily Market Updates

  • New M&A Activity
  • Industry Trends
  • Product Launches
  • Recalls
  • …and more

SmartTRAK
Medtech
Markets Covered

2 (7)

 

Orthopedics

Ortho Site of Care

Enabling Technologies

Injectables

Extremities

OrthoBio

Spine

Soft Tissue Fixation

Visualization

Total Joints

Trauma

Wound Care

Advanced Wound Care

Conventional Wound Care

Surgical Matrices

Regenerative Medicine

Amniotic Tissue

Cell Processing

Neuro Therapies

Neurovascular

Neuromodulation

Medtech News & Analysis

Recent blog posts

From Idea to Innovation: The Development of a Kangaroo Tendon Xenograft

BLT CEO and Founder Dr. Nick Hartnell discusses his work developing an off-the-shelf, biological soft-ti...

ICRS 2026 Summit: Daniel Grande Previews Key Topics in Joint Restoration

Ahead of the ICRS Summit in Porto, SmartTRAK interviews Past President Dr. Daniel Grande on key joint re...

A New Era in Wound Care: Merakris CEO on MTX-001

Senior analyst Elizabeth Anderson interviews Merakris Therapeutics CEO Chris Broderick about MTX-001, an...